Secondary amyloidosis in Crohn's disease: Treatment with tumour necrosis factor inhibitor [3]

Gut

Volumn 55, Issue 2, 2006, Pages 294-295

  Bosca M M ^a   Perez Bayloch C M ^a   Solis, M A ^a   Anton R ^a   Mayordomo, E ^a   Pons, S ^a   Minguez M ^a   Benages, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; COLCHICINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; SUBSTANCE P; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AMYLOIDOSIS; ANUS DISEASE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; CROHN DISEASE; DOPPLER FLOWMETRY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; MALE; NEPHROSIS; PRIORITY JOURNAL; PROTEINURIA; RECTUM BIOPSY;

ADULT; AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; HUMANS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30944435807     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.082057     Document Type: Letter

References (10)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
2. Merlini G, Belloti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-96.
3. Torregrosa E, Hernãndez-Jaras J, Calvo C, et al. Amiloidosis secundaria (AA) y afectaciõn renal. Nefrología 2003;XXIII:321-6.
4. Rysavá R, Merta M, Spicka, et al. Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant 2003;18:v38-v40.
5. Iñarrairaegui M, Arín A, Zozaya JM, et al. Enfermedad Inflamatoria Intestinal y Amiloidosis. Gastroenterol Hepatol 2004;27:260-3.
6. Bort MJ, Redondo CA, Miró SF, et al. Brown bowel syndrome: diagnostic and therapeutic problems. Rev Esp Enferm Dig 1992;81:280-4.
7. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
8. Ori Elkayam, Hawkins PN, Lachmann H, et al. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum 2002;46:2571-3.
9. Gottenberg JE, Merle-Vicent F, Bentaberry F, et al. Anti-tumor necrosis factor a therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritis. Arthritis Rheum 2003;48:2019-24.
10. Nakayama M, Kashiwagi M, Katafuchi R, et al. Resolution of primary amyloidosis by melphalan and prednisone: a case report. Clin Nephrol 2005:63:215-20.